167 related articles for article (PubMed ID: 36568513)
1. Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis.
Wang L; Wang Y; Cheng X; Li X; Li J
Transl Oncol; 2023 Feb; 28():101605. PubMed ID: 36568513
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis.
Marty S; Lamé G; Guével E; Priou S; Chatellier G; Tournigand C; Kempf E;
BMC Cancer; 2024 Jan; 24(1):143. PubMed ID: 38287348
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer.
Basu Roy U; Baird AM; Ciupek A; Fox J; Manley E; Norris Xx K; Scagliotti GV; Wakelee HA; Mitsudomi T; Clark RC; Arndt R; Hirsch FR; Bunn PA; Smeltzer MP
JTO Clin Res Rep; 2022 Feb; 3(2):100269. PubMed ID: 34961851
[No Abstract] [Full Text] [Related]
4. Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression.
Xu Y; Xu J; Qiao R; Zhong H; Xia J; Zhong R
Transl Oncol; 2023 Jul; 33():101671. PubMed ID: 37068401
[TBL] [Abstract][Full Text] [Related]
5. Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months.
Deng Y; Ma J; Zhao S; Yang M; Sun Y; Zhang Q
Transl Oncol; 2023 Feb; 28():101614. PubMed ID: 36584488
[TBL] [Abstract][Full Text] [Related]
6. Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC.
Jiang YJ; Zhang TT; Zhu YQ; Cai HQ; Chang C; Hao JJ; Cai Y; Wang MR; Liang JW; Zhang Y
Transl Oncol; 2023 Feb; 28():101609. PubMed ID: 36571988
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy sensitizes locally advanced esophageal squamous cell carcinoma to PD-1 blockade for a higher pathological complete response rate and survival.
Wang P; Lei M; Weng G; Huang R; Lin H; Wei W; Chen Y; He H; Chen P; Zhang D; Chen W; Zhou H; Gao P; Liu S; Wang F
Transl Oncol; 2023 Oct; 36():101736. PubMed ID: 37478670
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing.
Zhang Z; Cao C; Zhou CL; Li X; Miao C; Shen L; Singla RK; Lu X
Transl Oncol; 2023 Oct; 36():101741. PubMed ID: 37523897
[TBL] [Abstract][Full Text] [Related]
9. Receptor-interacting protein kinase 1 (RIPK1) regulates cervical cancer cells via NF-κB-TNF-α pathway: An in vitro study.
Bai W; Cui F; Wang Z; Gu X; Fang X; Zhou L; Guo S
Transl Oncol; 2023 Oct; 36():101748. PubMed ID: 37516007
[TBL] [Abstract][Full Text] [Related]
10. CircSLC39A8 attenuates paclitaxel resistance in ovarian cancer by regulating the miR‑185‑5p/BMF axis.
Liu Y; Shen Z; Wei X; Gu L; Zheng M; Zhang Y; Cheng X; Fu Y; Lu W
Transl Oncol; 2023 Oct; 36():101746. PubMed ID: 37499410
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience.
Chiru ED; Grasic Kuhar C; Oseledchyk A; Schötzau A; Gonzalez MJ; Kurzeder C; Vetter M
Transl Oncol; 2023 Oct; 36():101724. PubMed ID: 37480708
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of alpha-fetoprotein-positive gastric cancer revealed by analysis of cancer databases and transcriptome sequencing data.
Li Y; Lin Y; Zhao L; Yang C; Wang B; Gao Z; Ye Y; Wang S; Shen Z
Transl Oncol; 2023 Oct; 36():101737. PubMed ID: 37478671
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DLEU1 promotes proliferation and glycolysis of gastric cancer cells via APOC1 upregulation by recruiting SMYD2 to induce trimethylation of H3K4 modification.
Xu H; Ba Z; Liu C; Yu X
Transl Oncol; 2023 Oct; 36():101731. PubMed ID: 37478669
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA FENDRR suppresses cancer-associated fibroblasts and serves as a prognostic indicator in colorectal cancer.
Li F; Yang J; Li Y; Tan Z; Li H; Zhang N
Transl Oncol; 2023 Oct; 36():101740. PubMed ID: 37487432
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b
Wang Q; Zhang N; Liu L; Ma L; Tan Y; Liu X; Wu J; Chen G; Li X; Liang Y; Zhou F
Cell Oncol (Dordr); 2023 Oct; 46(5):1253-1268. PubMed ID: 37071330
[TBL] [Abstract][Full Text] [Related]
16. The Effect of immunonutrition in patients undergoing pancreaticoduodenectomy: a systematic review and meta-analysis.
Fan Y; Li N; Zhang J; Fu Q; Qiu Y; Chen Y
BMC Cancer; 2023 Apr; 23(1):351. PubMed ID: 37069556
[TBL] [Abstract][Full Text] [Related]
17. Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer.
Li J
BMC Cancer; 2023 Apr; 23(1):353. PubMed ID: 37069549
[TBL] [Abstract][Full Text] [Related]
18. The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level.
Chu Z; Yang S; Li Q; Shang J; Ren Z; Ren F
BMC Cancer; 2023 Apr; 23(1):346. PubMed ID: 37069523
[TBL] [Abstract][Full Text] [Related]
19. Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study.
Zhang J; Lin Z; Zhou J; Huang Y; Chen S; Deng Y; Qiu M; Chen Y; Hu Z
BMC Cancer; 2023 Apr; 23(1):342. PubMed ID: 37055773
[TBL] [Abstract][Full Text] [Related]
20. Automated Breast Ultrasound (ABUS)-based radiomics nomogram: an individualized tool for predicting axillary lymph node tumor burden in patients with early breast cancer.
Chen Y; Xie Y; Li B; Shao H; Na Z; Wang Q; Jing H
BMC Cancer; 2023 Apr; 23(1):340. PubMed ID: 37055722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
